Physician profile
Sang Sim
NPI 1902845464
$16,112.37
in general payments reported to CMS, 2019-2025
14 companies · $4,473 in 2025
The $4,473 reported for 2025 was more than what 94% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $38.00 · 2022: $4,643 · 2023: $6,587 · 2025: $4,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,950 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,438 · Travel and Lodging: $1,992 · Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,950.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,437.50 |
| Travel and Lodging | $1,991.93 |
| Food and Beverage | $681.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $6,568.05 | 2022-2023 | |
| Boston Scientific Corporation | $4,444.59 | 2022 | |
| Teleflex LLC | $3,508.52 | 2025 | Barrigel |
| Histosonics, INC. | $964.57 | 2025 | |
| Elekta, INC. | $325.65 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $56.76 | 2022-2023 | Truebeam |
| Novocure INC. | $55.74 | 2019 | |
| Sumitomo Pharma America, INC. | $49.77 | 2023 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $39.24 | 2019 | |
| Mevion_medical_systems_inc | $33.53 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.41 | 2019-2020 | |
| Varian Medical Systems, INC. | $16.24 | 2019 | |
| Eisai INC. | $14.03 | 2019 | |
| Celgene Corporation | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sang Sim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.